Journal article
Impact of COVID-19 on a real-world treat-and-extend regimen with aflibercept for neovascular age-related macular degeneration
Abstract
OBJECTIVE: To assess the effect of the COVID-19 pandemic on injection intervals among patients treated for neovascular age-related macular degeneration.
DESIGN: Retrospective cohort study.
Authors
Nanji K; Kennedy K; Fung M; Xie J; Hatamnejad A; Garg SJ; Wykoff CC; Chaudhary V
Journal
Canadian Journal of Ophthalmology, Vol. 60, No. 1, pp. e92–e99
Publisher
Elsevier
Publication Date
2 2025
DOI
10.1016/j.jcjo.2024.05.027
ISSN
0008-4182
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
HumansRetrospective StudiesIntravitreal InjectionsCOVID-19MaleFemaleVisual AcuityWet Macular DegenerationAgedRecombinant Fusion ProteinsReceptors, Vascular Endothelial Growth FactorAngiogenesis InhibitorsSARS-CoV-2Tomography, Optical CoherenceAged, 80 and overVascular Endothelial Growth Factor ATreatment OutcomeFollow-Up Studies